156 related articles for article (PubMed ID: 22974315)
1. Targeting cells causing split tolerance allows fully allogeneic islet survival with minimal conditioning in NOD mixed chimeras.
Al-Adra DP; Pawlick R; Shapiro AM; Anderson CC
Am J Transplant; 2012 Dec; 12(12):3235-45. PubMed ID: 22974315
[TBL] [Abstract][Full Text] [Related]
2. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
[TBL] [Abstract][Full Text] [Related]
3. Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.
Lin J; Chan WFN; Boon L; Anderson CC
Front Immunol; 2018; 9():837. PubMed ID: 29740442
[TBL] [Abstract][Full Text] [Related]
4. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
[TBL] [Abstract][Full Text] [Related]
5. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
Xu H; Zhu Z; Huang Y; Bozulic LD; Hussain LR; Yan J; Ildstad ST
Transplantation; 2012 Mar; 93(5):469-76. PubMed ID: 22228418
[TBL] [Abstract][Full Text] [Related]
6. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.
Nikolic B; Onoe T; Takeuchi Y; Khalpey Z; Primo V; Leykin I; Smith RN; Sykes M
Transplantation; 2010 Jan; 89(1):23-32. PubMed ID: 20061915
[TBL] [Abstract][Full Text] [Related]
7. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
[TBL] [Abstract][Full Text] [Related]
8. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
Guo Z; Wu T; Sozen H; Pan Y; Heuss N; Kalscheuer H; Sutherland DE; Blazar BR; Hering BJ
Transplantation; 2003 Apr; 75(7):909-15. PubMed ID: 12698073
[TBL] [Abstract][Full Text] [Related]
9. Nonobese diabetic natural killer cells: a barrier to allogeneic chimerism that can be reduced by rapamycin.
Al-Adra DP; Chan WF; Anderson CC
Transplantation; 2011 Nov; 92(9):977-84. PubMed ID: 21956197
[TBL] [Abstract][Full Text] [Related]
10. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
11. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
12. Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion.
Liu B; Hao J; Pan Y; Luo B; Westgard B; Heremans Y; Sutherland DE; Hering BJ; Guo Z
Am J Transplant; 2006 May; 6(5 Pt 1):933-46. PubMed ID: 16611329
[TBL] [Abstract][Full Text] [Related]
13. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.
Wu T; Levay-Young B; Heuss N; Sozen H; Kirchhof N; Sutherland DE; Hering B; Guo Z
Transplantation; 2002 Jul; 74(1):22-7. PubMed ID: 12134094
[TBL] [Abstract][Full Text] [Related]
14. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.
Seung E; Iwakoshi N; Woda BA; Markees TG; Mordes JP; Rossini AA; Greiner DL
Blood; 2000 Mar; 95(6):2175-82. PubMed ID: 10706892
[TBL] [Abstract][Full Text] [Related]
16. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.
Nikolic B; Takeuchi Y; Leykin I; Fudaba Y; Smith RN; Sykes M
Diabetes; 2004 Feb; 53(2):376-83. PubMed ID: 14747288
[TBL] [Abstract][Full Text] [Related]
17. Toward minimal conditioning protocols for allogeneic chimerism in tolerance resistant recipients.
Al-Adra DP; Anderson CC
Chimerism; 2013; 4(1):23-5. PubMed ID: 23328386
[TBL] [Abstract][Full Text] [Related]
18. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
19. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
Jin MX; Engelstad K; Oluwole SF
Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
[TBL] [Abstract][Full Text] [Related]
20. T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model.
Pilat N; Farkas AM; Mahr B; Schwarz C; Unger L; Hock K; Oberhuber R; Aumayr K; Wrba F; Wekerle T
J Heart Lung Transplant; 2014 Apr; 33(4):429-37. PubMed ID: 24468120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
